Banca de QUALIFICAÇÃO: EDERSON KERLAKIAN DE PAIVA GOMES FERNANDES

Uma banca de QUALIFICAÇÃO de MESTRADO foi cadastrada pelo programa.
STUDENT : EDERSON KERLAKIAN DE PAIVA GOMES FERNANDES
DATE: 10/06/2025
TIME: 14:30
LOCAL: DEPARTAMENTO DE ODONTOLOGIA-SALA III
TITLE:

STUDY OF THE OCCURRENCE AND ASSOCIATION OF POTENTIALLY MALIGNANT ORAL DISORDERS AND ORAL SQUAMOID CARCINOMA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

KEY WORDS:

Type 2 Diabetes Mellitus; Potentially Malignant Oral Disorders; Oral Squamous Cell Carcinoma.

PAGES: 47
BIG AREA: Ciências da Saúde
AREA: Odontologia
SUMMARY:

Diabetes Mellitus is a global epidemic affecting millions of people worldwide, with increasing incidence rates, particularly in developing countries such as Brazil. Approximately 90% of DM cases are of type 2 (DM2), which is characterized by insulin resistance, physical inactivity, and obesity. Studies have shown that patients with DM2 are at an elevated risk of developing malignant neoplasms. Oral Squamous Cell Carcinoma (OSCC) is one of the most common malignant neoplasms in the Brazilian population, particularly among men over the age of 40. It is important to highlight that OSCC can be preceded by the development of lesions known as Potentially Malignant Oral Disorders (PMOD). Although some studies report an association between DM2 and the increased risk of malignant neoplasms, few have explored the relationship between PMOD, OSCC, and DM2. This study is designed as a retrospective, observational, and cross-sectional research, focusing on the analysis and recording of clinical and histopathological characteristics of patients obtained from their medical records, as well as complementary tests performed to assess glycemic index. The primary objective is to investigate the occurrence and association between PMOD and OSCC in patients diagnosed with type 2 Diabetes Mellitus (DM2). The results will be presented through descriptive statistical analysis, using a significance level of 5% (p≤0.05). The goal of this study is to provide relevant data to optimize clinical management of these patients and develop follow-up protocols that facilitate the early diagnosis of PMOD and OSCC. It is expected that the findings will contribute to the reduction of mortality and public healthcare costs related to the treatment of DM2 and its associated complications.

COMMITTEE MEMBERS:
Interna - 3218128 - AMANDA KATARINNY GOES GONZAGA
Interna - 2492713 - ERICKA JANINE DANTAS DA SILVEIRA
Presidente - 2644142 - PATRICIA TEIXEIRA DE OLIVEIRA